Beta-glucans are natural fibers that act two ways depending on source. Grain forms reliably lower cholesterol and smooth blood sugar after meals — the strongest, best-supported benefit. Yeast and mushroom forms engage the immune system for infections and cancer support, but evidence is mixed. Source and dose matter more than the name; digestive upset is the main downside. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | < 100 mg/dL (often < 70 if high cardiovascular risk) | Primary target of cereal beta-glucan |
| Apolipoprotein B (ApoB) | < 80 mg/dL | Counts the artery-clogging particles; more precise than LDL alone |
| Total cholesterol | < 180 mg/dL | Broad lipid overview that beta-glucan lowers alongside LDL |
| HDL cholesterol | > 50 mg/dL (women), > 40 mg/dL (men) | Confirms beta-glucan is not lowering the protective fraction |
| Triglycerides | < 100 mg/dL | Complements the lipid picture; sensitive to carbohydrate load |
| Fasting glucose | 70–90 mg/dL | Tracks the longer-term glucose effect |
| HbA1c | < 5.4% | Reflects average blood sugar over ~3 months |
| hs-CRP | < 1.0 mg/L | Optional marker of inflammation for immune-focused use |
Cadence: Baseline before starting; recheck lipids and glucose ~6–12 weeks after reaching the target dose, then every 6–12 months (more often if medication doses are being adjusted).